FDA gives emergency approval to Eli Lilly’s arthritis drug paired with remdesivir for treating hospitalized coronavirus patients – after WHO warns NOT to use the antiviral FDA issued emergency use authorization for the use of Eli Lilly’s rheumatoid arthritis drug baricitinib in combination with remdesiver to treat COVID-19 The approval, made Thursday, comes as World … Read more
The arthritis drug tocilizumab can help critically-ill Covid-19 patients recover, a large British trial has found. Patients given the drug in a clinical trial led by Imperial College London were found to be 87 per cent more likely to see their symptoms improve within 28 days than patients not given the drug. But because the … Read more
‘I’d been feeling stressed and had not been sleeping much,’ recalls Dasha, who was 19 at the time. ‘I thought it was conjunctivitis’ Student Dasha Karzunina assumed at first that the red, painful eye she had developed while revising for her university exams was a simple infection. ‘I’d been feeling stressed and had not been … Read more
Arthritis drug ‘cuts elderly Covid-19 deaths by two-thirds’, say researchers – raising hopes that it will save the most vulnerable Daily drug reduces deaths by 71 per cent in those with moderate or severe illness Drug baricitinib, marketed as Olumiant, has only been available for three years Medics hope the arthritis drug could help save most … Read more
NHS patients with rheumatoid arthritis are to benefit from a breakthrough drug that eases the agonising pain in joints. The condition affects 400,000 Britons – many of them young adults – who can be left wheelchair-bound due to the pain and energy-sapping exhaustion it causes. Current treatments are able to soothe pain and dampen inflammation … Read more
Arthritis drug improves survival odds for COVID-19 patients treated with remdesivir by 35%, NIH study finds An NIH trial tested a combination of Eli Lilly’s arthritis drug, barcitinib, and the antiviral remdesivir to treat COVID-19 Overall, those who got both drugs were 35% more likely to survive than those given remdesivir alone People on supplemental … Read more
Coronavirus patient, 41, becomes first in the UK to receive experimental arthritis drug in trial to treat Covid-19 Farhan Hamid, 41, has been in intensive care at Manchester Royal Infirmary Received dose of otilimab – potential arthritis treatment – to see effect on Covid Study trial is being funded by GlaxoSmithKline who aim to recruit 800 patients By … Read more
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases. The result have not yet been … Read more
Could TURMERIC fight off the pain of arthritis? Scientists reveal the yellow spice is more effective than a placebo at relieving knee pain Turmeric is widely used as a flavouring in South Asian cooking It has been used as a traditional Eastern medicine for centuries But it is only in recent years that science has … Read more
Is Acterma the next severe COVID-19 treatment? All seven critically ill patients recovered from their fevers and needed less oxygen to breathe after treatment with arthritis drug in small new study Researchers looked at coronavirus patients who have cytokine storms, which occur when the body attacks its own cells and tissues They found these cytokines … Read more